HC2

20-HYDROXYCHOLESTEROL

Created:	2005-05-09
Last modified:	2020-06-05

Find Related PDB Entry
2 entries where HC2 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	75
Chiral Atom Count	8
Bond Count	78
Aromatic Bond Count	0

2D diagram of HC2

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	20-HYDROXYCHOLESTEROL
Synonyms	(3BETA,20R)-CHOLEST-5-ENE-3,20-DIOL
Systematic Name (OpenEye OEToolkits)	(3S,8S,9S,10R,13S,14S,17S)-17-[(2R)-2-hydroxy-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Formula	C₂₇ H₄₆ O₂
Molecular Weight	402.653
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	OC(C4C3(C(C1C(C2(C(=CC1)CC(O)CC2)C)CC3)CC4)C)(C)CCCC(C)C
SMILES	CACTVS	3.341	CC(C)CCC[C](C)(O)[CH]1CC[CH]2[CH]3CC=C4C[CH](O)CC[C]4(C)[CH]3CC[C]12C
SMILES	OpenEye OEToolkits	1.5.0	CC(C)CCCC(C)(C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O
Canonical SMILES	CACTVS	3.341	CC(C)CCC[C@@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC(C)CCC[C@](C)([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O
InChI	InChI	1.03	InChI=1S/C27H46O2/c1-18(2)7-6-14-27(5,29)24-11-10-22-21-9-8-19-17-20(28)12-15-25(19,3)23(21)13-16-26(22,24)4/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t20-,21-,22-,23-,24-,25-,26-,27+/m0/s1
InChIKey	InChI	1.03	MCKLJFJEQRYRQT-MGNSQDQZSA-N

Drug Info: DrugBank

DrugBank ID	DB04704
Name	20-hydroxycholesterol
Groups	experimental
Synonyms	20-hydroxycholesterol
Categories	Cholestanes Cholestenes Fused-Ring Compounds Lipids Membrane Lipids Oxysterols Steroids Sterols
CAS number	516-72-3

Related Resource References

Resource Name	Reference
Pharos	CHEMBL1233249
PubChem	440711
ChEMBL	CHEMBL1233249

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.